These latter authors focused on these two transporters in part because their co-expression correlates with poor outcome in a range of cancer types, but not if co-expressed with IDO1: perhaps this explains the small number of IDO1-expressing tumours in which the two transporters co-associate. This evidence concerns the gene IDO1 and cancer.